Related Experiment Video
Updated: Aug 9, 2025

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
Published on: April 23, 2021
Effects of intensive vs. standard blood pressure control on cognitive function: Post-hoc analysis of the STEP
Jiali Fan1, Jingjing Bai1, Wei Liu2
1Department of Hypertension, National Center for Cardiovascular Diseases, Fuwai Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
Insights
Intensive blood pressure control in older adults did not significantly alter cognitive function, as measured by the Mini-Mental State Examination. This finding suggests intensive systolic blood pressure lowering may not impact global cognition in this population.
Area of Science:
- Gerontology
- Cardiology
- Neurology
Background:
- The Strategy of Blood Pressure Intervention in older Hypertensive Patients (STEP) trial demonstrated cardiovascular benefits of intensive systolic blood pressure (SBP) control.
- This secondary analysis investigates the impact of intensive SBP lowering on cognitive function in older hypertensive patients.
Purpose of the Study:
- To evaluate the effect of intensive versus standard SBP control on cognitive function in hypertensive individuals aged 60-80 years.
- To determine if intensive SBP lowering influences the rate of cognitive decline as assessed by the Mini-Mental State Examination (MMSE).
Main Methods:
- A multicenter, randomized controlled trial involving 6,501 hypertensive patients aged 60-80 years.
- Participants were assigned to intensive (SBP 110-130 mmHg) or standard (SBP 130-150 mmHg) treatment groups.
- Cognitive function was assessed annually using the MMSE; cognitive decline was defined by a score below education-specific cutoffs.
Main Results:
- No significant difference in the annual change of MMSE scores between the intensive (-0.001) and standard (0.030) treatment groups (p=0.052).
- The incidence of cognitive decline was similar in both groups: 1.4% in the intensive group and 1.3% in the standard group (HR 0.005, p=0.983).
- Median follow-up was 3.34 years.
Conclusions:
- Intensive SBP control, compared to standard treatment, did not lead to a significant change in global cognitive function among older hypertensive patients.
- The study suggests that intensive blood pressure lowering, within the tested range, may not have a discernible impact on cognitive function using the MMSE.
Background:
The STEP (Strategy of Blood Pressure Intervention in the older Hypertensive Patients) trial showed that intensive systolic blood pressure (SBP) control resulted in a lower incidence of cardiovascular events than standard treatment. This study analyzed the effects of intensive SBP lowering on cognitive function.
Methods:
STEP was a multicenter, randomized controlled trial of hypertensive patients aged 60-80 years. Participants were randomly assigned (1:1) to SBP goals of 110-130 mmHg (intensive treatment) or 130-150 mmHg (standard treatment). Each individual was asked to complete a cognitive function test (Mini-Mental State Examination; MMSE) at baseline and during follow-up. The primary outcome for this study was the annual change in MMSE score. Subjects with a score less than education-specific cutoff point were categorized as cognitive decline.
Results:
The analysis enrolled 6,501 participants (3,270 participants in the intensive-treatment and 3,231 participants in the standard-treatment groups). Median follow-up was 3.34 years. There was a minor change in MMSE score, with an annual change of -0.001 [95% confidence interval [CI] -0.020, 0.018] and 0.030 (95% CI 0.011, 0.049) in the intensive- and standard-treatment groups, respectively (p = 0.052). Cognitive decline occurred in 46/3,270 patients (1.4%) in the intensive-treatment group and 42/3,231 (1.3%) in the standard-treatment group (hazard ratio 0.005, 95% CI 0.654, 1.543, p = 0.983).
Conclusions:
Compared with standard treatment, intensive SBP treatment did not result in a significant change in cognitive function test score. The impact of intensive blood pressure lowering was not evident using this global cognitive function test.
Trial Registration:
ClinicalTrials.gov. Unique identifier: NCT03015311.
Related Concept Videos
Pre-Procedural Guidelines for Assessing Blood Pressure
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension V: Nursing Management
Hypertension IV: Drug Therapy and Lifestyle Modifications
Errors occurring during blood pressure monitoring
Several factors...
Hypertension and Regulation of Blood Pressure

